FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to dermatology and immunology, and can be used for treating patients with acne. External application of adapalene gel + clindamycin and oral administration of tetracycline are performed. Additionally, Betukladin is taken orally 2 times a day in dose of 350 mg for 30 days.
EFFECT: method enables reducing the length of treatment, alleviating the clinical course, reducing eosinophils and the level of immunoglobulins E in the blood, due to the combined use of external therapy, antibacterial therapy and oral administration of Betukladin, which contains lichen β-oligosaccharides and has adsorbing properties.
1 cl, 5 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ACNE TREATMENT REMEDY | 2020 |
|
RU2764574C1 |
| METHOD OF TREATING ACNE | 2011 |
|
RU2455009C1 |
| METHOD OF TREATMENT OF ACNE VULGAR | 2023 |
|
RU2796315C1 |
| METHOD OF TREATING ACNE (VERSIONS) | 2023 |
|
RU2822952C1 |
| METHOD OF TREATING ACNE | 2017 |
|
RU2674981C1 |
| METHOD OF TREATING EXCHORINATED ACNE | 2018 |
|
RU2699061C1 |
| METHOD FOR CHOOSING THERAPY IN CASE OF ACNE | 2003 |
|
RU2252014C1 |
| METHOD OF TREATING MODERATE ACNE | 2010 |
|
RU2425682C1 |
| METHOD OF TREATING ATOPIC DERMATITIS IN CHILDREN WITH SECONDARY IMMUNODEFICIENCY SYNDROME | 2014 |
|
RU2542421C1 |
| METHOD FOR ASSESSING THE SEVERITY OF BRONCHIAL ASTHMA EXACERBATION USING AN INTEGRAL INDICATOR | 2021 |
|
RU2765432C1 |
